Wound Skin Substitutes Market - A Global and Regional Analysis: Focus on Region, Country-Level Analysis, and Competitive Landscape - Analysis and Forecast, 2023-2030
Introduction of Wound Skin Substitutes The global wound skin substitutes market, valued at $1,181.0 million in 2022, is on a robust growth trajectory and is anticipated to reach $2,062.6 million... もっと見る
SummaryIntroduction of Wound Skin SubstitutesThe global wound skin substitutes market, valued at $1,181.0 million in 2022, is on a robust growth trajectory and is anticipated to reach $2,062.6 million by 2030. This market is expected to expand at a compound annual growth rate (CAGR) of 7.35% between 2023 and 2030. Driven by the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, the market is witnessing a surge in demand for innovative and effective wound healing solutions. Market Introduction Technological advancements in biomaterials and the development of more efficient skin substitute products are further fueling this growth. Moreover, the rising geriatric population, which is more prone to chronic conditions, and the expanding capabilities of healthcare infrastructures globally are significant contributors to the market’s expansion. This growth has also been supported by a growing focus on improving patient outcomes and reducing the overall healthcare costs associated with chronic wounds. Regional Segmentation: • North America o U.S. o Canada • Europe o U.K. o Germany o France o Italy o Spain o Netherlands o Switzerland o Russian Federation o Turkey o Poland o Belgium o Sweden o Ireland o Norway o Austria o Denmark o Finland o Portugal o Czech Republic o Romania o Greece o Slovakia o Ukraine • Asia-Pacific o Japan o China o India o South Korea o Australia o Malaysia o Thailand • Latin America o Brazil o Mexico o Colombia o Argentina o Chile • Rest-of-the-World The global wound skin substitutes market has been dominated by North America, which held a 78.12% share in 2022. This significant share can be attributed to several factors, including an aging population, the steep rise in the prevalence of obesity that is heavily correlated to diabetes, and the late effects of radiation therapies. These factors have further boosted the adoption of wound skin substitutes among patients, thereby boosting revenue growth. Asia-Pacific, Europe, and Latin America regions are expected to witness significant growth in the wound skin substitutes market due to a surge in the incidence rate of chronic wounds, technological advancements leading to the development of innovative products, and increasing healthcare expenditure. Recent Developments in the Wound Skin Substitutes Market • In July 2023, Coloplast announced an agreement to acquire Kerecis for up to $1.3 billion. Kerecis has pioneered patented technology for treating wounds and burns by utilizing unaltered fish skin. • In April 2023, Coloplast (Kerecis) announced MariGen Shield, which integrates the company’s proven fish-skin graft with a silicone contact layer for treating chronic and complex wounds. • In January 2023, Coloplast (Kerecis) announced the release of two new products for the burn market, GraftGuide Mano and GraftGuide Micro. This latest innovation is a specialized fish skin product tailored for treating burns specifically on the hand. • In January 2022, Researchers from the University of Birmingham and the University of Huddersfield, UK, developed a new 3D bioprinting technique that could be used to treat chronic wounds. • In October 2021, Coloplast (Kerecis) received authorization from the FDA to market Kerecis Omega3 SurgiBind. This implant is a fish-skin graft that can be implanted for plastic and reconstructive surgical procedures. How can this report add value to an organization? Product/Innovation Strategy: By understanding specific regional needs and preferences highlighted in the report, a company can tailor its product development to address local market demands effectively. This might include innovation in skin substitute materials that cater to prevalent wound types in a particular region. Growth/Marketing Strategy: With detailed regional data, companies can craft precise marketing strategies that resonate with local healthcare providers and patients. This includes choosing the right channels and messages that appeal to the specific demographic and economic conditions of the region. Competitive Strategy: The report provides an analysis of key competitors in the region, allowing companies to benchmark their products and strategies. Knowing the competitive landscape helps in positioning their offerings more effectively to capture market share. Methodology Key Considerations and Assumptions in Market Engineering and Validation • The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030. • The scope of this report has been carefully derived based on interactions with experts in different companies worldwide. This report provides a market study of upstream and downstream products of wound skin substitutes. • The market contribution of wound skin substitutes anticipated to be launched in the future has been calculated based on the historical analysis of the solutions. • Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history. • The market has been mapped based on the available wound skin substitute solutions. This report has considered and profiled all the key companies with significant offerings in this field. Primary Research: The primary sources involve industry experts in wound skin substitutes, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study. The key data points taken from the primary sources include: • Validation and triangulation of all the numbers and graphs • Validation of the report’s segmentation and key qualitative findings • Understanding the competitive landscape and business model • Current and proposed production values of a product by market players • Percentage split of individual markets for regional analysis Secondary Research Open Sources • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others • Annual reports, SEC filings, and investor presentations of the leading market players • Company websites and detailed study of their product portfolio • Gold standard magazines, journals, white papers, press releases, and news articles • Paid databases The key data points taken from the secondary sources include: • Segmentations and percentage shares • Data for market value • Key industry trends of the top players of the market • Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation • Quantitative data for mathematical and statistical calculations Key Market Players and Competition Synopsis The competitive landscape of the wound skin substitutes market has been characterized by the presence of several key players, each offering a range of specialized products. Coloplast, for instance, has made significant strides with products such as MariGen Shield, GraftGuide Mano, and GraftGuide Micro, which are tailored to address various aspects of wound care, particularly burns and complex wounds. The companies are not only innovating in product development but also expanding their market reach and setting industry standards in the treatment of complex wounds. This dynamic competitive environment underscores the continuous evolution and technological advancement within the wound care industry. Some prominent names established in this market are: • Coloplast • Smith & Nephew • MTF Biologics • MiMedx Group, Inc • AlloSource • Organogenesis Inc. • RTI Surgical • LifeNet Health • Molecular Biologicals, Inc Table of ContentsExecutive Summary1 Market 1.1 Product Definition 1.2 Inclusion and Exclusion Criteria 1.2.1 Inclusion 1.2.2 Exclusion Criteria 1.3 Key Questions Answered 1.4 Analysis and Forecast Note 1.5 Key Findings 2 Regions 2.1 Regional Summary 2.2 North America 2.2.1 U.S. 2.2.2 Canada 2.3 Europe 2.3.1 Germany 2.3.2 U.K. 2.3.3 France 2.3.4 Italy 2.3.5 Spain 2.3.6 Turkey 2.3.7 Netherlands 2.3.8 Russian Federation 2.3.9 Switzerland 2.3.10 Poland 2.3.11 Austria 2.3.12 Czech Republic 2.3.13 Sweden 2.3.14 Romania 2.3.15 Ireland 2.3.16 Belgium 2.3.17 Greece 2.3.18 Portugal 2.3.19 Norway 2.3.20 Slovakia 2.3.21 Denmark 2.3.22 Ukraine 2.3.23 Finland 2.4 Asia-Pacific 2.4.1 China 2.4.2 Japan 2.4.3 India 2.4.4 South Korea 2.4.5 Australia 2.4.6 Thailand 2.4.7 Malaysia 2.5 Latin America 2.5.1 Brazil 2.5.2 Mexico 2.5.3 Argentina 2.5.4 Colombia 2.5.5 Chile 2.6 Rest-of-the-World 3 Markets - Competitive Benchmarking 3.1 Key Strategies and Developments 3.2 Key Companies Ecosystem 4 Research Methodology 4.1 Data Sources 4.1.1 Primary Data Sources 4.1.2 Secondary Data Sources 4.1.3 Data Triangulation 4.2 Market Estimation and Forecast List of Figures Figure 1: Global Wound Skin Substitutes Market, $Million, 2022, 2026, and 2030 Figure 2: Global Wound Skin Substitutes Market (by Region), $Million, 2022, 2026, and 2030 Figure 3: Key Industry Trends in Global Wound Skin Substitutes Market Figure 4: U.S. Wound Skin Substitutes Market, $Million, 2021-2030 Figure 5: Canada Wound Skin Substitutes Market, $Million, 2021-2030 Figure 6: Germany Wound Skin Substitutes Market, $Million, 2021-2030 Figure 7: U.K. Wound Skin Substitutes Market, $Million, 2021-2030 Figure 8: France Wound Skin Substitutes Market, $Million, 2021-2030 Figure 9: Italy Wound Skin Substitutes Market, $Million, 2021-2030 Figure 10: Spain Wound Skin Substitutes Market, $Million, 2021-2030 Figure 11: Turkey Wound Skin Substitutes Market, $Million, 2021-2030 Figure 12: Netherlands Wound Skin Substitutes Market, $Million, 2021-2030 Figure 13: Russian Federation Wound Skin Substitutes Market, $Million, 2021-2030 Figure 14: Switzerland Wound Skin Substitutes Market, $Million, 2021-2030 Figure 15: Poland Wound Skin Substitutes Market, $Million, 2021-2030 Figure 16: Austria Wound Skin Substitutes Market, $Million, 2021-2030 Figure 17: Czech Republic Wound Skin Substitutes Market, $Million, 2021-2030 Figure 18: Sweden Wound Skin Substitutes Market, $Million, 2021-2030 Figure 19: Romania Wound Skin Substitutes Market, $Million, 2021-2030 Figure 20: Ireland Wound Skin Substitutes Market, $Million, 2021-2030 Figure 21: Belgium Wound Skin Substitutes Market, $Million, 2021-2030 Figure 22: Greece Wound Skin Substitutes Market, $Million, 2021-2030 Figure 23: Portugal Wound Skin Substitutes Market, $Million, 2021-2030 Figure 24: Norway Wound Skin Substitutes Market, $Million, 2021-2030 Figure 25: Slovakia Wound Skin Substitutes Market, $Million, 2021-2030 Figure 26: Denmark Wound Skin Substitutes Market, $Million, 2021-2030 Figure 27: Ukraine Wound Skin Substitutes Market, $Million, 2021-2030 Figure 28: Finland Wound Skin Substitutes Market, $Million, 2021-2030 Figure 29: China Wound Skin Substitutes Market, $Million, 2021-2030 Figure 30: Japan Wound Skin Substitutes Market, $Million, 2021-2030 Figure 31: India Wound Skin Substitutes Market, $Million, 2021-2030 Figure 32: South Korea Wound Skin Substitutes Market, $Million, 2021-2030 Figure 33: Australia Wound Skin Substitutes Market, $Million, 2021-2030 Figure 34: Thailand Wound Skin Substitutes Market, $Million, 2021-2030 Figure 35: Malaysia Wound Skin Substitutes Market, $Million, 2021-2030 Figure 36: Brazil Wound Skin Substitutes Market, $Million, 2021-2030 Figure 37: Mexico Wound Skin Substitutes Market, $Million, 2021-2030 Figure 38: Argentina Wound Skin Substitutes Market, $Million, 2021-2030 Figure 39: Colombia Wound Skin Substitutes Market, $Million, 2021-2030 Figure 40: Chile Wound Skin Substitutes Market, $Million, 2021-2030 Figure 41: Data Triangulation Figure 42: Top-Down and Bottom-Up Approach Figure 43: Assumptions and Limitations List of Tables Table 1: Market Snapshot Table 2: Global Wound Skin Substitutes Market, Opportunities Table 3: Global Wound Skin Substitutes Market (by Region), $Million, 2021-2030 Table 4: North America Wound Skin Substitutes Market (by Country), $Million, 2021-2030 Table 5: Europe Wound Skin Substitutes Market (by Country), $Million, 2021-2030 Table 6: Asia-Pacific Wound Skin Substitutes Market (by Country), $Million, 2021-2030 Table 7: Latin America Wound Skin Substitutes Market (by Country), $Million, 2021-2030 Table 8: Rest-of-the-World Wound Skin Substitutes Market (by Country), $Million, 2021-2030 Table 9: Key Initiatives, 2021-2024 Table 10: Key Companies, Global Wound Skin Substitutes Market Press Release
The global wound skin substitutes market is estimated to reach $2,062.6 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 7.35% during the forecast period 2023-2030.
The wound skin substitutes market has been growing steadily over the past decade, driven by factors such as the aging population, the steep rise in the prevalence of obesity that is heavily correlated to diabetes, and the late effects of radiation therapies. The market for wound skin substitute goods has increased globally because of an increase in reported burns, infections, skin illnesses, injuries, etc. USPs of this report • Wound skin substitutes market opportunities across regions • Wound skin substitutes industry overview in the next decade • Detailed regional analysis of the market • Key strategies and developments in the market • Ecosystems of the key companies Analyst Perspective According to Swati Sood, Principal Analyst – BIS Research, The global wound skin substitutes market is poised for significant growth, driven by technological innovations in biologics and a rising prevalence of chronic wounds. As healthcare systems increasingly focus on cost-effective and efficient wound care solutions, the market is expected to see a steady expansion, underpinned by advancements in regenerative medicine and increased healthcare spending. Key Questions Answered in the Report • What is the estimated global market size for the wound skin substitutes market? • What are the key findings in the wound skin substitutes market? • What is the growth potential of the global wound skin substitutes market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? • Who are the leading players with significant products in the wound skin substitutes market? • What strategies have been adopted by the key players in the wound skin substitutes market? • How is each region of the wound skin substitutes market expected to grow during the forecast period, and what is the anticipated revenue generated by each country by the end of 2030?
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
BIS Research社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(skin)の最新刊レポート
よくあるご質問BIS Research社はどのような調査会社ですか?多数のアナリストチームと大規模な業界専門家のネットワークを擁するBISリサーチは、市場に影響を与える革新的な技術に関して、高度なマーケットインテリジェンスを提供しています。特に、新興テクノロジーに関す... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |